Sintilimab and Lenalidomide as a Treatment for CAEBV
Learn more about:
Related Clinical Trial
Selinexol Combined With Dexamethasone in the Treatment of CAEBV
Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV
EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
Sintilimab and Lenalidomide as a Treatment for CAEBV
Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)